未经检查的自反应性CD8+T细胞在癌症免疫治疗中造成了严重破坏
Anthony Wong1,2,3, Slava Epelman1,2,3,4,5
1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Nature cardiovascular research
|July 9, 2024
概括
细胞毒性T细胞在接受免疫治疗的癌症患者中识别心脏,导致心肌炎. 在免疫抑制个体中识别这些T细胞点可以预测治疗风险.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫疗法已经彻底改变了癌症治疗,但可能会导致与免疫相关的不良事件.
- 心肌炎是心肌的炎症,是某些癌症免疫疗法的严重副作用.
- T细胞在免疫反应中起着至关重要的作用,包括识别自我抗原.
研究的目的:
- 在接受免疫治疗的癌症患者中,识别T细胞识别的特定心脏标.
- 了解免疫疗法诱导的心肌炎的免疫学基础.
- 为了在开始治疗之前能够预测心肌炎的个体风险.
主要方法:
- 对癌症和免疫治疗诱导的心肌炎患者对心脏的T细胞反应的分析.
- 免疫分析以识别心脏蛋白内T细胞表位.
- 与临床结果相关联的T细胞反应性.
主要成果:
- 在患有心肌炎的患者中,发现细胞毒性T细胞对特定的心脏产生反应.
- 已识别的心脏点被表现为T细胞介导的心脏损伤的潜在触发因素.
- 在有癌症免疫治疗史的患者中观察到这种反应性.
结论:
- 对心脏的T细胞识别是免疫疗法诱导的心肌炎的关键机制.
- 识别这些T细胞点可以帮助分层患有心肌炎风险的患者.
- 这些知识可以指导开发更有针对性,更安全的免疫疗法策略.
相关概念视频
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
Cytotoxic T Cells-mediated Immune Response
886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


